Maxim starts HCV Phase II

Maxim (MAXM; SSE:MAXM) started in Europe and Israel a Phase II trial of its Ceplene (formerly Maxamine) histamine dihydrochloride to treat hepatitis C virus (HCV) patients who have failed prior therap...